CS Paper Radar

Disentangling and Fusing Neurostructural and Vascular Ageing for Retinal Age Prediction

Junwen Zheng, Li Rong Wang, Anthony Zihan Lin, Xinran Xu, Wei Kiong Ngo, Kelvin Zhenghao Li, Tock Han Lim, Xiuyi Fan

eess.IV ·submitted 2026-09-29 13:00 UTC · v2
published

Abstract

Estimating biological age is an important task in ageing research, as it quantifies individual ageing trajectories beyond chronological age. Retinal age estimation has become a well-established direction in this area because retinal imaging provides a non-invasive window into neural and microvascular ageing. Existing studies, however, have predominantly focused on fundus photographs and usually model retinal ageing as a single generic process. Although biological ageing is heterogeneous and different organs or tissues may age at different rates, little research has explicitly distinguished neurostructural and vascular ageing in retinal age prediction. This work fills this gap by studying neurostructural ageing with Optical Coherence Tomography (OCT) images and vascular ageing with Optical Coherence Tomography Angiography (OCTA) images. We formulate multimodal OCT/OCTA retinal age estimation as a structural-vascular ageing decomposition problem and propose SAP-DPF, a unified dual-path prediction framework that separately estimates structural and vascular ageing, models modality-specific predictive uncertainty, and adaptively fuses the two ageing signals through an uncertainty-gated late-fusion module. Using this unified prediction framework, SAP-DPF achieves a mean absolute error of 4.07 years for the structural pathway and 7.37 years for the vascular pathway, while the proposed late-fusion algorithm further improves the overall mean absolute error to 4.02 years, representing a 12.52% improvement over the strongest single-modality baseline. This work could extend retinal age prediction beyond a single biological-age estimate, providing a framework for investigating structural and vascular contributions to heterogeneous retinal ageing.

Comment
Accepted as a short paper at IEEE BIBM 2026

Closest papers

Nearest neighbours by meaning across the whole index.

A Disease-specific Retinal Aging Biomarker for Predicting Progression to Late Age-related Macular Degeneration

cs.CV ·2026-11-12 ·Hexin Dong, Benjamin Hou, Puzhen Wu, Mingquan Lin, Emily Y. Chew +2 more
similarity 0.70
Abstract · 41 pages, 13 figures (including supplementary material)

Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss in older adults. While chronological age is a primary risk factor, it inadequately reflects individual variations in retinal aging, limiting effective AMD risk stratification and timely intervention. Here, we propose and validate fundus-based AMD age (FAA), which quantifies disease-specific retinal aging in AMD and captures accelerated AMD-related retinal aging, thereby improving prognostic precision over chronological age. Trained on 36,782 images from 2,192 participants in the Age-Related Eye Disease Study (AREDS) dataset and validated across AREDS and AREDS2 cohorts, our model demonstrates significant improvements over traditional chronological age-based approaches. Specifically, integrating the proposed FAA into Cox proportional-hazards models significantly enhances prediction performance. FAA improved the C-index from 0.836 to 0.888 and reduced the 5-year Brier score from 0.050 to 0.046 in AREDS, with consistent gains observed in AREDS2 (C-index 0.715 to 0.756; 2-year Brier 0.078 to 0.076). FAA showed improved prognostic performance across the two datasets and under different phenotype definitions (reading center-defined vs. specialist-defined grading), supporting its potential utility for AMD risk stratification. These findings highlight the advantage of incorporating FAA into AMD risk prediction frameworks, supporting further evaluation of FAA for AMD risk stratification.

0.21

Retinal OCTA Phenotyping with LLM Reporting for Alzheimer's Disease

cs.CV cs.CL ·2026-09-04 ·Progga Paromita Dutta, Jeba Maliha, Md Rafiul Kabir
similarity 0.65
Abstract · 4th IEE International Conference on Artificial Intelligence, Blockchain, and Internet of Things, (AIBThings)

Early identification of Alzheimer's disease (AD) remains challenging because established assessment methods can be costly, resource-intensive, or unsuitable for population-scale screening. Optical coherence tomography angiography (OCTA) provides non-invasive visualization of retinal microvasculature, but existing approaches often require diagnostic labels and provide limited measurement-level interpretation. We present an explainable OCTA pipeline that integrates annotation-aware vessel segmentation, layer-specific vascular biomarker extraction, label-free phenotyping, and measurement-grounded LLM reporting. Using 117 ROSE-1 images from 39 subjects, we apply annotation-matched segmentation models to superficial vascular complex (SVC), deep vascular complex (DVC), and combined SVC+DVC representations. The models achieve ROC-AUC values of 0.916-0.970 and Dice scores of 0.695-0.781. Six density and fractal-dimension biomarkers form subject-level profiles for exploratory clustering. Analysis of nine held-out subjects identifies an internally consistent lower-density, lower-fractal-dimension phenotype, although the absence of diagnostic labels prevents clinical interpretation. Reports generated using GPT, Gemini, and Llama are evaluated for measurement grounding, citation faithfulness, and diagnostic caution. Overall, the framework provides a transparent, non-diagnostic connection between retinal vascular measurements, exploratory phenotyping, and evidence-linked interpretation for Alzheimer's research.

0.12

Exploring the Latent Structure of AMD Severity Using Retinal Foundation Models

eess.IV cs.CV ·2026-10-09 ·Niccolò Fineschi, Jovana Panic, Atsushi Watanabe, Hideaki Hayashi, Kazuya Nishimura +5 more
published similarity 0.62
Abstract · 7 pages, 5 figures. Accepted for publication at IEEE EMBS BHI 2026

Retinal foundation models have demonstrated strong performance across a wide range of ophthalmic tasks, yet relatively little is known about how disease-related information is represented within their learned embeddings and whether this distribution influences downstream prediction performance. In this work, we use Age-related Macular Degeneration (AMD) as a case study to investigate how disease severity is represented within the embedding space of RET-CLIP, a retinal vision-language foundation model, using bilateral fundus images from the AREDS dataset, benchmarked against non-retinal encoders. We first characterize the distribution of AMD severity within the learned representation space and then evaluate how this structure influences classification performance across three clinically relevant task formulations of increasing granularity. Finally, we analyze the most influential latent dimensions combining feature attribution, statistical phenotype association, and qualitative image analyses. Our results show that RET-CLIP represents AMD severity as a continuous spectrum rather than a set of discrete categories, with healthy and advanced disease stages exhibiting clearer separation than intermediate ones. This organization was reflected in downstream performance, which decreased from a balanced accuracy of 0.844 and 0.814 for binary AMD and Late-AMD detection respectively to 0.446 for six-class grading. Furthermore, the most influential latent dimensions were statistically associated to distinct retinal phenotypes, including drusen accumulation, pigmentary alterations, and advanced retinal lesions. These findings suggest that the structure of retinal foundation-model representations influences the difficulty of clinically relevant prediction tasks and demonstrate the potential of representation-level analysis for understanding disease organization and improving interpretability.

0.18

Self-supervised Pre-training Helps Retinal Disease Progression Modelling Most When Data Is Scarce

cs.CV ·2026-09-11 ·Ifeoma Veronica Nwabufo, Julius Gervelmeyer, Sarah Müller, Philipp Berens
similarity 0.59
Abstract

Modelling how a disease progresses over time requires longitudinal imaging cohorts, which are scarce and small, whereas cross-sectional data -- one image per participant -- is abundant. Self-supervised pre-training on such data offers a way to bridge this gap, but it is unclear which strategy best supports progression modelling, or how that answer depends on the amount of labelled longitudinal data. We study this for age-related macular degeneration (AMD), pre-training encoders on the large cross-sectional NAKO cohort and predicting time to late AMD on the longitudinal AREDS dataset. We compare in-house self-supervised encoders against a general-purpose (DINOv2) and a domain-specific (RETFound) foundation model, across contrastive, masked-autoencoding, and self-distillation objectives, under frozen and fine-tuned protocols, and across labelled training sets from 100 to 32,250 examples. Which model performs best depends on how the encoder is used. When the encoder is frozen and labels are few -- the regime typical of longitudinal cohorts -- pre-trained representations reach clinically reasonable discrimination from a few hundred labelled samples, while models trained from scratch do not; this advantage fades under fine-tuning. Transfer is governed by the self-supervision objective rather than corpus scale or domain match, so that an encoder pre-trained on a modest cross-sectional cohort matches or exceeds a far larger in-domain foundation model. Together, these results offer a practical recipe for building progression models where longitudinal data is scarce: a frozen self-supervised encoder with a lightweight survival head.

0.15

Modelling Geographic Atrophy Progression using Implicit Neural Representations

cs.CV cs.AI ·2026-08-11 ·Simone Sarrocco, Paul Friedrich, Florentin Bieder, Christina Bornberg, Philippe Valmaggia +2 more
publishedcode/data similarity 0.58
Abstract · Accepted at MICCAI 2026 Off-Grid Workshop

Age-related Macular Degeneration (AMD) is the major cause of blindness in the Western world. Its late dry phase is characterised by irreversible atrophic areas, namely Geographic Atrophy (GA). Longitudinal Fundus Autofluorescence (FAF) image acquisitions are currently the main tool for assessing lesion growth over time at the image level. However, due to its highly individualised progression, the evolution of late AMD remains poorly understood. In this work, we propose using Implicit Neural Representations (INRs) to model GA progression at the individual level in a low-data setting. Our approach generates both FAF and GA segmentation at both past and future time points. Among the comparison models, our method achieves competitive segmentation quality across different scenarios, yielding the lowest Mean Absolute Error (MAE) for the GA lesion area and the highest DICE score, without sacrificing FAF image quality. The code is available at https://github.com/SimoneSarrocco/ga-progression-with-inrs.

0.38

A Novel Conditional Adversarial Diffusion Model for High-Fidelity OCT-to-OCT Image Translation and Precise Anti-VEGF Therapy Response Prediction in Diabetic Macular Edema

eess.IV cs.CV ·2026-11-02 ·Reza Rasti, Armin Biglari, Sobhan Mohammadi Hafshejani, Alireza Dehghani, Michael J. Allingham +1 more
code/data similarity 0.58
Abstract · 18 pages, 8 figures, 6 tables, Submitted to IEEE Journal of Biomedical and Health Informatics

Diabetic macular edema (DME) is a leading cause of severe vision loss among working-age adults. Although intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections currently serve as the first-line therapy for DME, a notable subset of patients fails to respond despite the substantial cost and clinical burden, suggesting they may benefit more from alternative interventions. Automated, noninvasive pre-treatment response assessment could therefore spare non-responders from the current trial-and-error treatment paradigm. In this study, we propose a novel conditional adversarial diffusion framework that synthesizes post-treatment optical coherence tomography (OCT) images from baseline scans, enabling the derivation of each patient's initial response to anti-VEGF therapy. The model was developed with subject-level 5-fold cross-validation on a US cohort (n = 127) and externally validated on an independent Iranian cohort (n = 44). Benchmarked against fourteen baseline and state-of-the-art translation models, the proposed model achieved the best treatment-response prediction performance among the methods evaluated for that task on both cohorts, with balanced accuracies of 85.7% and 93.0% on the US cohort and 85.2% and 95.3% on the external Iranian cohort at the 10% and 20% central subfield thickness reduction thresholds, respectively. Ultimately, this framework offers a decision-support tool to help ophthalmologists anticipate initial anti-VEGF outcomes in DME prior to treatment initiation, toward personalized therapy selection. The source code will be made publicly available upon acceptance.

0.40

A Visual Grounding Benchmark for Retinal OCT with Multimodal Large Language Models

cs.CV ·2026-10-22 ·Ronald Fecso, José Morano, Botond Fazekas, Paul Widmann-Sedlnitzky, Dorota Himel +4 more
benchmarkcode/data similarity 0.58
Abstract · Under review at npj digital medicine

Multimodal large language models (MLLMs) can answer clinical questions about medical images, but trustworthy use requires visual grounding: models should localize the pathology they report rather than rely on spurious shortcuts. Whether MLLMs can visually ground clinical findings in retinal optical coherence tomography (OCT), the most widely used imaging modality in ophthalmology, remains largely unexplored. To address this gap, we introduce RetinaGroundBench, the first benchmark for biomarker visual grounding in retinal OCT. It comprises 815 B-scans exhaustively annotated by ophthalmologists with 4,537 bounding boxes covering 13 biomarkers across 8 diseases. Because MLLMs often fragment a single lesion into multiple partial predictions, we propose AggIoU, a metric that evaluates whether the union of overlapping predicted boxes covers the annotated region. Across 27 open-source MLLMs (0.8-38B parameters), we find that visual grounding remains largely unsolved: the best general-purpose model achieves a macro F1 of just 23.7%, with consistently low recall, despite reaching up to 73% balanced accuracy on biomarker presence questions. To narrow this gap, we developed RetGrounder, an MLLM fine-tuned using an OCT-specific strategy integrating grounding and textual information. Despite its relatively small size (8B), RetGrounder improves grounding F1 to 33.9%, a 43% relative improvement. Our benchmark provides a reference point for measuring progress in the field of OCT diagnosis with MLLMs.

0.30

Automated 2D and 3D Segmentation of AMD and DME Lesions in OCT

cs.CV ·2026-08-27 ·Lucia Sundberg, Zhihao Zhao, M. Ali Nasseri
similarity 0.57
Abstract

Age-related macular degeneration (AMD) and diabetic macular edema (DME) are leading causes of vision loss, and optical coherence tomography (OCT) is the standard modality for detecting and monitoring the subtle lesions that drive treatment decisions. Most deep-learning segmentation work for OCT is validated only in-domain, leaving generalization to clinical data collected under different acquisition protocols largely untested. This work develops and systematically ablates four lesion-segmentation pipelines -- 2D and 3D variants for AMD and DME -- reaching Dice scores of 0.76 to 0.82 with strong volumetric and surface calibration (r vol, r surf greater than or equal to 0.97 across all four pipelines) on an in-domain validation set. The ablation process establishes a full-volume, calibration-aware adoption standard that catches mechanisms an ordinary slice-level evaluation would keep, and identifies ensemble composition as the most consistent driver of improvement. To test generalization, the models are evaluated on OLIVES, an external clinical cohort with no lesion-level ground truth, using a proxy-metric framework built around biomarker AUROC, central subfield thickness (CST) correlation, and longitudinal concordance. Predictions track clinical biomarkers outside the training distribution, though less strongly than in-domain -- evidence for, not validation of, automated lesion-burden tracking as a clinical tool.

0.25